Therapeutic miR-132 inhibition reverses heart failure

31 August 2019 (14:32 - 14:46)

Organised by:

About the speaker

Professor Thomas Thum

Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover (Germany)

4 More presentations in this session

Presentation thumbnail

Exome variants influencing cholesterol levels and the risk of recurrent ischemic events after early-onset myocardial infarction

Doctor D. Ardissino (Ospedale parma, IT)

Presentation thumbnail

In silico model for specific antigen-driven response of T-lymphocytes in the epicardial adipose tissue: unravelling the intricate skein of microbiota involvement in acute coronary syndromes

Doctor D. Pedicino (Rome, IT)

Presentation thumbnail

A different microbial signature in plaque and gut of patients presenting with ACS: a possible role for coronary instability

Doctor P. Eugenia (Rome, IT)

Presentation thumbnail

Circulating dipeptidyl peptidase-3 is a myocardial depressant factor: Procizumab promptly and sustainably restored hemodynamics in heart failure

Professor A. Mebazaa (Paris, FR)

Access the full session

Session thumbnail

Late Breaking Basic and Translational Science - Acute Coronary Syndromes and Heart Failure

The Event

ESC Congress 2019

31 August 2019 14:32 CET

You may be interested in

Congress Presentation

The chronic heart failure evolutions: different fates and routes

Congress Session

Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

Congress Session

Which device might help your HFpEF patient?

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources